A. Kröhn

发表

Rational design of peptide-based HIV proteinase inhibitors.

I B Duncan, J. Kay, D. Taylor, 1990, Science.

The design and synthesis of the Angiotensin Converting Enzyme inhibitor Cilazapril and related bicyclic compounds

S. Redshaw, C. Hassall, G. Lawton, 1986 .

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

I B Duncan, H. Jacobsen, K. Yasargil, 1995, Virology.

New potent inhibitors of angiotensin converting enzyme

S. Redshaw, C. Hassall, G. Lawton, 1984, FEBS letters.

The design of a new group of angiotensin‐converting enzyme inhibitors

C. Moody, C. Hassall, Antonin Kröhn, 1982, FEBS letters.

The design and synthesis of new triazolo, pyrazolo-, and pyridazo-pyridazine derivatives as inhibitors of angiotensin converting enzyme

C. Moody, C. Hassall, Christopher J. Moody, 1984 .

Peptido-aminobenzophenones-novel latentiated benzo-1,4-diazepines

S. W. Holmes, C. Hassall, C. E. Smithen, 1977, Experientia.

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.

M. Hatada, B. Graves, S. Redshaw, 1991, Journal of medicinal chemistry.